Abstracts tagged "juvenile arthritis and juvenile idiopathic arthritis (JIA)"

Abstract Number: 2277 • 2017 ACR/ARHP Annual Meeting
Safety of Biologic Therapies for the Treatment of Juvenile Idiopathic Arthritis: Results from the Spanish Registry of Adverse Events with Biologic Therapies (BIOBADASER)
Juan José Bethencourt Baute¹, Carlos Sánchez-Piedra², Lorena Expósito Pérez¹, M. Victoria Hernández³, Javier Manero⁴, Rosa Rosello⁵, Fernando Sánchez-Alonso⁶, Dolores Ruiz-Montesinos⁷, Eva Perez Pampín⁸, Carlos Rodriguez-Lozano⁹, Cristina Campos Fernandez¹⁰, Cristina Fernández-Carballido¹¹, Raquel Martín-Domenech¹¹, Javier Del Pino-Montes¹², Mercedes Freire¹³, Federico Díaz-González¹⁴, Juan J. Gomez-Reino¹⁵ and Sagrario Bustabad¹⁶, ¹Servicio de Reumatología, Hospital Universitario de Canarias, Tenerife, Spain, ²Research Unit, Spanish Society of Rheumatology, Madrid, Spain, ³Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁴Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ⁵Hospital San Jorge, Huesca, Spain, ⁶Unidad de Investigación, Spanish Society of Rheumatology, Madrid, Spain, ⁷Rheumatology, Hospital Virgen Macarena, Seville, Spain, ⁸Rheumatology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, ⁹Hospital de Gran Canaria Dr. Negrín, Gran Canaria, Spain, ¹⁰Rheumatology, Hospital Universitario de Valencia., Valencia, Spain, ¹¹Hospital General Universitario de Elda, Elda, Spain, ¹²Rheumatology, HOSPITAL CLÍNICO UNIVERSITARIO DE SALAMANCA, Salamanca, Spain, ¹³Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, ¹⁴Servicio de Reumatología. Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, ¹⁵Fundacion Ramon Dominguez, Hospital Clinico Universitario, Santiago de Compostela, Spain, ¹⁶Rheumatology, Servicio de Reumatología. Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood. The treatment of JIA has been revolutionized by the use of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].